Gene expression profiles correlate with the morphology and metastasis characteristics of renal cell carcinoma cells

Oncology Reports

Volumn 13, Issue 1, 2005, Pages 75-80

  Ami, Yoshihiro ^a,b   Shimazui, Toru ^a   Akaza, Hideyuki ^a   Uematsu, Naoya ^a   Yano, Yukiko ^a   Tsujimoto, Gozoh ^c   Uchida, Kazuhiko ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Kitaibaraki City General Hospital   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Clustering; Kidney neoplasm; Microarray; Profiling; SKRC cell

Indexed keywords

ARTICLE; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UP-REGULATION;

EID: 18844384031     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.1.75     Document Type: Article

References (31)

1. Marumo K, Satomi Y, Miyao N, et al: The prevalence of renal cell carcinoma: a nation-wide survey in Japan in 1997. Int J Urol 8: 359-365, 2001. (Pubitemid 34225117)
2. Latif F, Tory K, Gnarra J, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317-1320, 1993. (Pubitemid 23231974)
3. Foster K, Prowse A, van den Berg A, et al: Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 3: 2169-2173, 1994.
4. Gnarra JR, Tory K, Weng Y, et al: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7: 85-90, 1994. (Pubitemid 24232386)
5. Herman JG, Latif F, Weng Y, et al: Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704, 1994. (Pubitemid 24311875)
6. Iliopoulos O, Kibel A, Gray S, Kaelin WG Jr: Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1: 822-826, 1995.
7. Ilson DH, Motzer RJ, Kradin RL, et al: A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma. J Clin Oncol 10: 1124-1130, 1992.
8. Ebert T, Bander NH, Finstad CL, Ramsawak RD, Old LJ: Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res 50: 5531-5536, 1990. (Pubitemid 20303015)
9. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470, 1995.
10. Hippo Y, Taniguchi H, Tsutsumi S, et al: Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 62: 233-240, 2002. (Pubitemid 34074010)
11. Hegde P, Qi R, Gaspard R, et al: Identification of tumor markers in models of human colorectal cancer using a 19, 200-element complementary DNA microarray. Cancer Res 61: 7792-7797, 2001. (Pubitemid 33049366)
12. Chen JJ, Peck K, Hong TM, et al: Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 61 : 5223-5230, 2001. (Pubitemid 32681557)
13. Van't Veer LJ, Dai H. van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536, 2002. (Pubitemid 34130608)
14. Seftor EA, Meltzer PS, Kirschmann DA, et al: Molecular determinants of human uveal melanoma invasion and metastasis Clin Exp Metastasis 19: 233-246, 2002. (Pubitemid 34553524)
15. Xu S, Mou H, Lu G, et al: Gene expression profile differences in high and low metastatic human ovarian cancer cell lines by gene chip. Chin Med J (Engl) 115: 36-41, 2002. (Pubitemid 34130432)
16. Chay CH, Cooper CR, Gendernalik JD, et al: A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines. Urology 60: 760-765, 2002. (Pubitemid 35300332)
17. Boer JM, Huber WK, Sultmann H, et al: Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res 11: 1861-1870, 2001. (Pubitemid 33100427)
18. Takahashi M, Rhodes DR, Furge KA, et al: Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 98: 9754-9759, 2001. (Pubitemid 32769376)
19. Zatyka M, da Silva NF, Clifford SC, et al: Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Cancer Res 62: 3803-3811, 2002. (Pubitemid 34728865)
20. Wilhelm M, Veltman JA, OIshen AB, et al: Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res 62: 957-960, 2002. (Pubitemid 34160268)
21. Young AN, Amin MB, Moreno CS, et al: Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol 158: 1639-1651, 2001. (Pubitemid 32422929)
22. Vasselli JR, Shin JH, Iyengar SR, et al: Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci USA 100: 6958-6963, 2003. (Pubitemid 36706375)
23. Shimazui T, Giroldi LA, Bringuier PP, Oosterwijk E, Schalken JA: Complex cadherin expression in renal cell carcinoma. Cancer Res 56: 3234-3237, 1996. (Pubitemid 26242969)
24. Klade CS, Voss T, Krystek E, et al: Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 1: 890-898, 2001. (Pubitemid 33587414)
25. Gunnersen JM, Spirkoska V, Smith PE, Danks RA, Tan SS: Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression. Glia 32: 146-154, 2000.
26. Kiuru M, Lehtonen R, Arola J, et al: Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res 62: 4554-4557, 2002.
27. Barker KT, Bevan S, Wang R, et al: Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer 87: 446-448, 2002. (Pubitemid 34983569)
28. Tsuchiya K, Reijo R, Page DC, Disteche CM: Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 57: 1400-1407, 1995.
29. Lau Y, Chou P, Iezzoni J, Alonzo J, Komuves L: Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet 91: 160-164, 2000. (Pubitemid 32110359)
30. Bartkova J, Zemanova M, Bartek J: Expression of CDK7/CAK in normal and tumor cells of diverse histogenesis, cell-cycle position and differentiation. Int J Cancer 66: 732-737, 1996. (Pubitemid 26197939)
31. Sawiris GP, Sherman-Baust CA, Becker KG, Cheadle C, Teichberg D, Morin PJ: Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Res 62: 2923-2928, 2002. (Pubitemid 34525780)